Melanoma Clinical Trials in Houston

Showing 181-200 of 241 trials

LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma

NCT01010984

The purpose of this study is to determine if LC beads loaded with Doxorubicin are a safe and effective treatment for melanoma that has spread to the liver.

Stage IV Melanoma

Robert C. Martin20 participantsStarted Sep 2009

Louisville, Kentucky, United States • Philadelphia, Pennsylvania, United States • Houston, Texas, United States

UNKNOWNPhase 1< 1 mile

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

NCT03098160

An immunotherapy study combining ipilimumab and evofosfamide for the treatment of patients with confirmed metastatic or locally advanced prostate cancer, metastatic pancreatic cancer, melanoma or human papillomavirus (HPV) negative squamous cell carcinoma of head and neck that have failed to respond to standard therapy, progressed despite standard therapy, for which standard therapy does not offer the potential for increased survival.

Pancreatic CancerMelanomaSquamous Cell Carcinoma of the Head and Neck+1 more

Threshold Pharmaceuticals69 participantsStarted May 2017

Houston, Texas, United States

TERMINATEDPhase 2< 1 mile

Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin

NCT01059305

The goal of this clinical research study is to learn if Tarceva ® (erlotinib) when taken before and after radiation and/or surgery can help to control aggressive cutaneous squamous cell carcinoma. The safety of the drug will also be studied.

Skin Cancer

M.D. Anderson Cancer Center10 participantsStarted Feb 2011

Houston, Texas, United States

LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin

Melanoma Trials in Other Cities

Prospective Measurement of Post-Treatment Lymphedema

Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma

In Vivo Confocal Microscopy Study of Pigmented Conjunctival Lesions

Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)

Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma

A Study of Vemurafenib in Participants With Metastatic Melanoma

A Study of Tasisulam in Treating Participants With Malignant Melanoma

Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma

Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System

Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients

Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)

Other Conditions in Houston